Evotec, Takeda Reach Multi-year Gene Therapy Research Alliance

(RTTNews) - Evotec SE (EVTCY.PK, EVOTF.PK) said that Evotec Gene Therapy, with operations in Austria, has formed a long-term research alliance with Takeda to support Takeda's research stage gene therapy discovery programmes. It did not disclose financial details of the agreement.

Meanwhile, Evotec has established a site for research and development of gene therapy-based projects: Evotec Gene Therapy which will start operations with a strong team of gene therapy experts at an R&D site in Orth/Donau, Austria.

As per the alliance with Takeda, Evotec will support multiple Takeda programmes targeting conditions aligned with Takeda's four core therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology.

The alliance leverages Evotec's growing gene therapy capabilities as well as Evotec's broader drug discovery platform.